Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
820.00    -11.00 (-1.32%)
Bid:
816.00
Ask:
822.00
Spread: 6.00 (0.735%)
Market Cap: £774.61m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

AUM Update

13 Apr 2017 07:00

RNS Number : 3750C
Polar Capital Holdings PLC
13 April 2017
 

13 April 2017

Polar Capital Holdings plc

AUM Update

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the boutique investment management group, today provides its regular quarterly update of its unaudited statement of its Assets under Management ("AUM").

 

Group AUM (unaudited)

 

Polar Capital reports that as at 31 March 2017 its AUM were £9.3bn compared to £7.3bn at the end of March 2016.

 

AUM movement in

twelve months to

31 March 2017

USD

GBP

Long only

funds

Alternative funds

Total

Long only

funds

Alternative funds

Total

AUM at

31 March 2016

$9,378m

$1,054m

$10,432m

£6,531m

£734m

£7,265m

Net subscriptions

/ (redemptions)

$(377)m

$(19)m

$(396)m

£(215)m

£(15)m

£(230)m

Market movement

and performance

$1,600m

$2m

$1,602m

£2,131m

£107m

£2,238m

Total AUM at

31 March 2017

$10,601m

$1,037m

$11,638m

£8,447m

£826m

£9,273m

 

Comment

 

It is encouraging to report a second consecutive quarter of net inflows. The £300m+ of net inflows in the final quarter of 2016 have been followed by 2017's first quarter delivering in excess of £200m of net inflows.

 

As 2017 commences it is also reassuring to note the positive performance of the Group's portfolio of funds as demonstrated by the table below that summarises the performance of the Group's Lipper rated UCITS funds as at 31 March 2017. The table shows that twelve out of eighteen funds are top quartile since launch and more recently, eleven are top quartile over one year. From this position of strength we feel that we are well positioned to benefit from the breadth and quality of our investment product and we look into the medium term with confidence.

 

Against this backdrop we commence our new financial year with our business more balanced than in recent years and are hopeful that the year ahead will deliver net inflows notwithstanding a significant correction in global equity markets.

 

 

1 year

3 years

5 years

Since

inception

1st quartile

11 funds

7 funds

7 funds

12 funds

2nd quartile

4 funds

5 funds

2 funds

6 funds

3rd quartile

3 funds

2 funds

1 fund

0 funds

4th quartile

0 funds

0 funds

1 fund

0 funds

 

 

For further information please contact:

 

Polar Capital

Tim Woolley (CEO)John Mansell (COO)

+44 (0)20 7227 2700

Canaccord Genuity - Nomad and Joint Broker

Simon Bridges (QE)

Andrew Buchanan

Kit Stephenson

+44 (0)20 7523 8000

 

Peel Hunt - Joint Broker

Guy Wiehahn

+44 (0)20 7418 8893

Camarco

Ed Gascoigne-Pees

 

+44 (0)20 3757 4984

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEASLAFLEXEFF
Date   Source Headline
18th Sep 202011:20 amRNSForm 8.3 - HASTINGS GROUP HOLDINGS PLC
10th Sep 202012:26 pmRNSForm 8.3 - HASTINGS GROUP
6th Aug 20203:31 pmRNSForm 8.3 - HASTINGS GROUP HOLDINGS PLC
3rd Aug 20207:00 amRNSBlock listing Interim Review
3rd Aug 20207:00 amRNSTotal Voting Rights
31st Jul 20207:30 amRNSIssue of Equity
30th Jul 20205:23 pmRNSForm 8.3 - HASTINGS GROUP HOLDINGS PLC
29th Jul 20207:00 amRNSResult of AGM
22nd Jul 20204:15 pmRNSIssue of Equity
22nd Jul 202012:10 pmRNSDirector/PDMR Shareholding
10th Jul 20202:07 pmRNSDirector/PDMR Shareholding
10th Jul 20202:06 pmRNSDirector/PDMR Shareholding
9th Jul 20207:00 amRNSAuM Update
7th Jul 20208:03 amRNSHolding(s) in Company
6th Jul 202010:08 amRNSDirector/PDMR Shareholding
3rd Jul 20207:00 amRNSForm 8.3 - Cello Health PLC
2nd Jul 20209:19 amRNSDirector/PDMR Shareholding
1st Jul 20202:10 pmRNSIssue of Equity
1st Jul 20207:00 amRNSTotal Voting Rights
29th Jun 202010:03 amRNSDirector/PDMR Shareholding
26th Jun 20201:10 pmRNSAnnual Financial Report
25th Jun 202010:26 amRNSHolding(s) in Company
25th Jun 202010:25 amRNSDirector/PDMR Shareholding
24th Jun 20203:29 pmRNSIssue of Equity
22nd Jun 20204:04 pmRNSDividend Declaration
22nd Jun 20207:00 amRNSGroup Audited Results for year ended 31 March 2020
18th Jun 202012:08 pmRNSSecond Price Monitoring Extn
18th Jun 202012:02 pmRNSPrice Monitoring Extension
5th Jun 202010:31 amRNSDirector/PDMR Shareholding
4th Jun 20207:16 amRNSNotice of Results
1st Jun 20207:00 amRNSTotal Voting Rights
19th May 20202:00 pmRNSIssue of Equity
12th May 202010:22 amRNSDirector/PDMR Shareholding
11th May 20201:15 pmRNSDirectorate Change
6th May 202011:36 amRNSHolding(s) in Company
4th May 20201:07 pmRNSIssue of Equity
4th May 202011:24 amRNSDirector/PDMR Shareholding
15th Apr 202012:00 pmRNSFund Termination
9th Apr 20204:26 pmRNSDirectorate Change
9th Apr 202012:02 pmRNSHolding(s) in Company
9th Apr 20207:00 amRNSAuM Update
7th Apr 20204:40 pmRNSSecond Price Monitoring Extn
7th Apr 20204:35 pmRNSPrice Monitoring Extension
7th Apr 20207:00 amRNSBoard Changes
1st Apr 20207:00 amRNSTotal Voting Rights
30th Mar 202012:08 pmRNSSecond Price Monitoring Extn
30th Mar 202012:02 pmRNSPrice Monitoring Extension
19th Mar 20204:41 pmRNSSecond Price Monitoring Extn
19th Mar 20204:37 pmRNSPrice Monitoring Extension
19th Mar 202012:07 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.